NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial ...